• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

FDA Drug Shortages

  • Print
  • Share
  • E-mail
-

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

 Formoterol Fumarate (FORADILĀ® AEROLIZERĀ®) Inhalation Powder

 Status: Discontinuation

 » Therapeutic Categories: Pulmonary/Allergy

Merck Sharp & Dohme Corp. (New 10/21/2015)

Company Contact Information:
800-672-6372

Presentation Posting Date Related Information
12 mcg capsules Unit dose (blister pack)Box of 60 (strips of 6)(NDC 0085-1401-01) 10/21/2015 Novartis (manufacturer) and Merck have jointly decided to voluntarily discontinue manufacture of FORADIL AEROLIZER for business reasons. It is anticipated that inventory will be exhausted and no longer distributed in or around January 2016, though inventory may be exhausted earlier. Health care providers are encouraged to identify an appropriate alternative treatment as soon as possible.
12 mcg capsules Unit Dose (blister pack)Box of 12 (strips of 6)(NDC 0085-1402-01) 10/21/2015 Novartis (manufacturer) and Merck have jointly decided to voluntarily discontinue manufacture of FORADIL AEROLIZER for business reasons. It is anticipated that inventory will be exhausted and no longer distributed in or around January 2016, though inventory may be exhausted earlier. Health care providers are encouraged to identify an appropriate alternative treatment as soon as possible.
-
-